NicVAX

BIOLOGICAL2 trials

Sponsors

Nabi Biopharmaceuticals, Yale University

Conditions

Nicotine DependenceSmoking CessationTobacco Use Cessation

Phase 2

Safety and Effectiveness of NicVAX in Treating Nicotine Dependent Individuals

CompletedNCT00218413

Nabi BiopharmaceuticalsSmoking Cessation, Tobacco Use Cessation

Start: 2004-10-31End: 2006-08-31Updated: 2017-01-12

Nicotine Vaccination and Nicotinic Receptor Occupancy

CompletedNCT00996034

Yale UniversityNicotine Dependence

Start: 2009-09-30End: 2011-02-28Updated: 2015-12-24